U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402382) titled 'Effects of an Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose Control in Peri/Post-Menopausal Women' on Oct. 22, 2025.
Brief Summary: The goal of this study is to better understand how an amylopectin chromium blend may influence whole body protein balance in women during midlife, when hormonal changes can adversely affect protein metabolism and muscle maintenance. Continuous glucose monitoring will also be used to assess glycemic control over a 24-hour period.
The main questions the study aims to answer are:
* Does the use of an amylopectin chromium blend in peri- and post-menopausal women help to support pos...